Your Health, We Care
Release date: 2024-08-13 13:49:37 Recommended: 151
Pemigatinib is indicated for adult patients with advanced, metastatic, or unresectable cholangiocarcinoma with FGFR2 fusion or rearrangement confirmed by testing.
Pemigatinib is indicated for patients with cholangiocarcinoma that has metastasized (i.e., spread to other parts of the body) or is locally advanced, and whose condition is no longer treatable by surgery.
Patients treated with Pemigatinib require genetic testing to confirm the presence of fusions or other rearrangement variants in the FGFR2 (fibroblast growth factor receptor 2) gene. Pemigatinib can effectively inhibit the growth and spread of this type of tumor by inhibiting the activity of FGFR2.
Patients should pay attention to the following before treatment with Pemigatinib to achieve the best treatment results.
Before taking Pemigatinib, patients need genetic testing to confirm whether their tumors have variants in FGFR2 or other related genes.
Pemigatinib may cause a range of side effects such as diarrhea, nausea, fatigue, etc. Patients should pay close attention to their own reactions during the course of medication and inform their doctor if they have any discomfort or worsening symptoms.
Many other medications can interact with Pemigatinib, so people should tell their doctor about all medications they are taking, including prescription drugs, over-the-counter medications, and supplements, before taking them.
Patients with cholangiocarcinoma may have negative emotions such as fear and depression, which are not easy to treat and recover from the disease and need timely psychological counseling from the patient's family.
Patients with cholangiocarcinoma often have negative emotions such as fear, anxiety, and depression, and medical staff should provide emotional support to encourage patients to maintain a positive attitude.
To the extent permitted by the medical protection system, patients are informed of their medical conditions and examination results, and their doubts and worries are reduced. At the same time, the treatment plan, surgical process, and possible prognosis of cholangiocarcinoma are explained to patients, so that patients can face the disease rationally.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
